Conversely, Black patients had a lesser risk of TP53 mutations in prostate cancer, KRAS mutations in pancreatic and endometrial cancers, and PIK3CA mutations in breast and endometrial cancers (Fig. 3B, D, and E). The gene discussed is TP53; the disease is prostate carcinoma.